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Malaria and Travel
to the Dominican
Republic
To the Editor: The rise in interna-
tional travel to malaria-endemic areas
in recent years has been followed by
an increase in the number of cases
diagnosed in countries where malaria
is not endemic (1). Tourist areas of the
Dominican Republic have traditional-
ly been considered to be low risk for
malaria transmission. However, over
the past few years, sporadic descrip-
tions of imported falciparum malaria
in travelers to these destinations have
been described (2,3). In spite of these
findings, neither the World Health
Organization nor the Centers for
Disease Control and Prevention rec-
ommend antimalarial chemoprophy-
laxis for trips to the Dominican
Republic’s main tourist resorts (4,5).
We report a new case of imported
malaria caused by mixed Plasmodium
vivax and P. malariae infection, with
unique clinical features, after a stan-
dard tourist trip to Puerto Plata (on the
northern coast of the Dominican
Republic). 
A31-year-old man with no relevant
medical history was treated in the
internal medicine department of our
hospital. He reported a history of poor-
ly defined malaise, night sweats, sleep-
lessness, tinnitus, and episodic diar-
rhea with no pathologic products dur-
ing the previous 6 days. He did not
report fever, chills, or headache. Two
weeks earlier, he had spent 10 days in
Puerto Plata in a tourist resort, without
traveling to any other place. He had not
received any antimalarial chemopro-
phylaxis. Physical examination
showed no abnormalities. Laboratory
values, including levels of sodium,
potassium, liver enzymes, creatinine,
and coagulation factors, as well as
results of hemogram and chest radi-
ograph, were within normal limits. A
blood film showed trophozoytes of P.
vivax and P. malariae. In a stool speci-
men, Entamoeba histolytica, Trichiuris
trichura, Endolimax nana, and Blasto-
cystis hominis were observed; stool
cultures were negative.
Treatment was initiated with
chloroquine (4 doses) and primaquine
for a period of 14 days; metronidazole
and paromomycin were administered
for the intestinal infestations.
Symptoms resolved in 48 hours, and
control blood films showed clearance
of the parasitemia. Two months after
the end of treatment, the patient
remained asymptomatic.
We describe a new and unusual
case of imported vivax-malariae
malaria. Two characteristics of our
patient’s case bear mention. First, the
place of acquisition of the infection
and the species of Plasmodium
involved are notable. The Dominican
Republic is considered a low-risk area
for malaria, although some places in
the west, on the Haitian border, are
malaria-endemic. In addition, accord-
ing to available information,
autochthonous malaria cases
increased after Hurricane George
(3,003 cases in 1999, compared to
2,000 in 1998) (6). Previously
described sporadic cases of imported
malaria from the Dominican Republic
included those in tourists who trav-
eled to Punta Cana, in the eastern part
of the country. All these cases were
caused by P. falciparum. To our
knowledge, no cases of P. vivax or
mixed P. vivax/P. malariae infection
have been described after travel to the
Dominican Republic (2,3). From
January 1999 to September 2003,
TropNetEurop (a European surveil-
lance network of tropical and import-
ed diseases) noted 618 cases of P.
vivax infection imported to Europe.
The most common areas of acquisi-
tion of P. vivax infection were the
Indian subcontinent (17%), Indonesia
(12.1%), South America (11.4%), and
West Africa (11.4%). Only 0.2% of
the cases of P. vivax infection were
acquired in the Caribbean, none of
them in the Dominican Republic (7).
Second, the clinical features were
atypical. Malaria usually starts as a
febrile syndrome, accompanied by
chills, headache, malaise, and
arthromyalgia. However, sometimes
symptoms are unspecific. In fact,
<10% of patients do not exhibit fever
or chills, and some report only poorly
defined complaints or other atypical
symptoms. Among these, gastroin-
testinal symptoms are the most fre-
quently reported (8). In the present
case, the syndrome could have been
easily explained by the intestinal
infestations detected in stool studies,
and malaria would have been over-
looked if the clinician had not taken
into account this disease in the diag-
nostic workup.
In summary, clinicians should
include malaria in the diagnostic
workup of tourists who become ill
after traveling to the Dominican
Republic. Species other than P. falci-
parum may be the cause of the dis-
ease; these species likely induce more
atypical forms of malaria. 
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Buruli Ulcer
Distribution in
Benin
To the Editor: Mycobacterium
ulcerans disease, commonly called
Buruli ulcer, is an emerging infectious
disease in West Africa (1,2). Several
forms of Buruli ulcer exist; large,
chronic ulcerations or indurated
plaques of the skin are the most fre-
quent manifestations of the disease
(1), and bone is sometimes involved
(3). Little is known about the focal
epidemiology of Buruli ulcer; inci-
dence, prevalence, and other data are
usually reported at the national or dis-
trict level (4). These data convey the
importance of the disease but do not
show the wide variations that occur at
the village level within a given
district. In 2002, we investigated
the disease in an arrondissement
(Gnizounmè) in an area in which
Buruli ulcer is endemic, the commune
of Lalo in Benin. Prevalence rates of
Buruli ulcer varied from 0.58 to 32.62
per 1,000 inhabitants of villages in the
same arrondissement. For Gnizounmè
Arrondissement, the overall preva-
lence was 10.70 per 1,000 inhabitants.
These results confirmed that distribu-
tion of Buruli ulcer must be deter-
mined at geopolitical divisions lower
than district or national levels, as is
frequently assumed to be the case.
An inverse relationship exists
between the prevalence of Buruli
ulcer and distance from the Couffo
River, which drains the arrondisse-
ment of Gnizounmè. A comparison of
the relevant data for Assogbahoué and
Tandji villages shows that the number
of patients per 1,000 inhabitants
increases gradually from 0.58 to
32.62 as the distance from the river
decreases from 10 to 1 km.
Recently, aquatic insects have
been considered potential vectors of
M. ulcerans (5,6). These aquatic
insects can fly many kilometers from
their source (7). This finding may par-
tially explain how patients who live
farther distances from their source of
water become infected, but not as
often as those who live closer. Some
water bugs obtained from water col-
lection points along the Couffo River
in the village of Tandji were found to
be positive for M. ulcerans by using
PCR with specific insertion sequence
2404 as a target (8).
If we consider domestic water
sources in the arrondissement of
Gnizounmè, only Tandji (32.62 Buruli
ulcer patients per 1,000 inhabitants)
used water directly from the Couffo
River. Other villages employed pro-
tected water sources for domestic pur-
poses (boreholes, cisterns, or piped
water from artesian wells). These
results are similar to Barker’s findings
in Uganda, which showed that fami-
lies who used unprotected sources of
water for domestic purposes had high-
er prevalence rates of Buruli ulcer
than those who used boreholes (9).
Consequently, besides the possible
influence of distance from the river on
disease prevalence through potential
vectors, such as insects or other fac-
tors, we hypothesize that the use of
river water for domestic purposes
may also play a role in the elevated
prevalence of the disease in Tandji
village. If this hypothesis is con-
firmed, preventive public health pro-
grams based on strategies that provide
protected water supply systems to vil-
lages must be developed to reduce the
frequency of the disease.
Determining the complex relation-
ship between distance from the
Couffo River and the numbers of
cases and level of protection of water
supply is difficult. Our findings argue
for the need to perform additional epi-
demiologic studies to understand
more completely the key factors that
determine the distribution of the dis-
ease in the entire commune of Lalo. 
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